首页> 美国卫生研究院文献>Journal of Korean Medical Science >Expression of MAGE-1 -2 and -3 genes in gastric carcinomas and cancer cell lines derived from Korean patients.
【2h】

Expression of MAGE-1 -2 and -3 genes in gastric carcinomas and cancer cell lines derived from Korean patients.

机译:MAGE-1-2和-3基因在来自韩国患者的胃癌和癌细胞系中的表达。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We investigated the expression of MAGE-1, -2, and -3 genes in tissues of 51 gastric carcinomas from Korean patients and in 11 gastric cancer cell lines established in Korea using reverse transcriptase-polymerase chain reaction along with immunohistochemical analyses and DNA sequencing. Among the 51 gastric carcinomas, MAGE-1, -2, and -3 genes were expressed in 16 (31%), 22 (43%), and 17 (33%), respectively, and 31 (60%) expressed at least one of the three genes. In contrast, none of the three MAGE genes were expressed in normal sites of gastric tissue from each cancer patient. Out of 11 gastric cancer cell lines, MAGE-1, -2, and -3 genes were expressed in two (18%), five (46%), and four (36%), respectively. According to the clinicopathological analysis, the expression of any of the three MAGE genes was not significantly correlated with several clinicopathological factors except histologic types (p= 0.067). Immunohistochemical analyses identified positive staining with monoclonal antibodies 77B and 57B specifically against MAGE-1 and -3 proteins, respectively, in nuclei and cytoplasms of cells in mRNA-positive tumor tissue. These findings suggest the possibility as a target for tumor-specific immunotherapy for Korean patients.
机译:我们使用逆转录酶-聚合酶链反应以及免疫组化分析和DNA测序研究了MAGE-1,-2和-3基因在韩国患者的51例胃癌组织中以及在韩国建立的11种胃癌细胞系中的表达。在51种胃癌中,MAGE-1,-2和-3基因分别在16种(31%),22种(43%)和17种(33%)中表达,至少31种(60%)表达。这三个基因之一。相反,每个癌症患者的胃组织正常部位均未表达这三个MAGE基因。在11种胃癌细胞系中,MAGE-1,-2和-3基因分别以两个(18%),五个(46%)和四个(36%)表达。根据临床病理学分析,除组织学类型外,三个MAGE基因任何一个的表达均与多种临床病理学因素无显着相关性(p = 0.067)。免疫组织化学分析确定了分别在mRNA阳性肿瘤组织的细胞核和细胞质中分别特异性抗MAGE-1和-3蛋白的单克隆抗体77B和57B的阳性染色。这些发现表明,有可能将其作为针对韩国患者的肿瘤特异性免疫治疗的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号